These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29419672)

  • 1. Pulse pressure and diabetes treatments: Blood pressure and pulse pressure difference among glucose lowering modality groups in type 2 diabetes.
    Alemi H; Khaloo P; Mansournia MA; Rabizadeh S; Salehi SS; Mirmiranpour H; Meftah N; Esteghamati A; Nakhjavani M
    Medicine (Baltimore); 2018 Feb; 97(6):e9791. PubMed ID: 29419672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
    Wulffelé MG; Kooy A; Lehert P; Bets D; Donker AJ; Stehouwer CD
    Diabet Med; 2005 Jul; 22(7):907-13. PubMed ID: 15975107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
    Kengne AP; Czernichow S; Huxley R; Grobbee D; Woodward M; Neal B; Zoungas S; Cooper M; Glasziou P; Hamet P; Harrap SB; Mancia G; Poulter N; Williams B; Chalmers J;
    Hypertension; 2009 Aug; 54(2):399-404. PubMed ID: 19470869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.
    Bakris GL; Ruilope LM; McMorn SO; Weston WM; Heise MA; Freed MI; Porter LE
    J Hypertens; 2006 Oct; 24(10):2047-55. PubMed ID: 16957566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    Intern Med; 2007; 46(22):1837-46. PubMed ID: 18025765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.
    Nachum Z; Zafran N; Salim R; Hissin N; Hasanein J; Gam Ze Letova Y; Suleiman A; Yefet E
    Diabetes Care; 2017 Mar; 40(3):332-337. PubMed ID: 28077460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis.
    Liang HL; Ma SJ; Xiao YN; Tan HZ
    Medicine (Baltimore); 2017 Sep; 96(38):e7939. PubMed ID: 28930827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.
    Donahue SR; Turner KC; Patel S
    Clin Pharmacokinet; 2002; 41(15):1301-9. PubMed ID: 12452739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients.
    Raptis AE; Tountas NB; Yalouris AG; Halvatsiotis PG; Raptis SA
    Horm Metab Res; 1996 Feb; 28(2):89-94. PubMed ID: 8867905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse pressure and chronic kidney disease in patients with type 2 diabetes.
    Tanaka M; Babazono T; Takeda M; Iwamoto Y
    Hypertens Res; 2006 May; 29(5):345-52. PubMed ID: 16832155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative study of circadian variations of ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects.
    Zhao ZY; Zhao ZY; Wang YQ; Yan ZH; Cui J; Li YY
    Clin Exp Hypertens; 2005; 27(2-3):187-94. PubMed ID: 15835381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
    Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
    Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
    Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
    Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
    Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
    Diabetes Res Clin Pract; 2015 Jan; 107(1):104-12. PubMed ID: 25458330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of costs for four oral antidiabetic regimens within a managed care population.
    Stockl K; Vanderplas AM; Nicklasson L
    Manag Care Interface; 2003 Jul; 16(7):31-6. PubMed ID: 12908215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuffless and noninvasive measurement of systolic blood pressure, diastolic blood pressure, mean arterial pressure and pulse pressure using radial artery tonometry pressure sensor with concept of Korean traditional medicine.
    Park M; Kang H; Huh Y; Kim KC
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3597-600. PubMed ID: 18002775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis.
    Tozawa M; Iseki K; Iseki C; Takishita S
    Kidney Int; 2002 Feb; 61(2):717-26. PubMed ID: 11849415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different blood pressure indices for the prediction of prevalent diabetic nephropathy in a sub-Saharan African population with type 2 diabetes.
    Choukem SP; Dzudie A; Dehayem M; Halle MP; Doualla MS; Luma H; Kengne AP
    Pan Afr Med J; 2012; 11():67. PubMed ID: 22655101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.